Archive | November, 2009
Depomed Receives Certification Notice (NASDAQ:DEPO)
Depomed, Inc (NASDAQ:DEPO) announced that they have received a Paragraph IV certification notice from Lupin Limited advising Depomed of the filing of an Abbreviated New Drug Application (ANDA) with the Food and Drug Administration for a generic version of GLUMETZA (metformin hydrochloride extended release tablet) of 500 mg and 1000 mg strengths.
Continue reading...Are Home Values Stabilizing? Well Sort Of.
11 November 2009 – 6:30 am PST
Comments Off
Zillow Real Estate (www.zillow.com) reports that Americans with negative equity in their single-family homes fell to 21% in the third quarter which is 2 percentage points better than the second quarter at 23%. The bad news is that some of that improvement is because more homeowners were forced into foreclosure so the homes were taken [...]
Continue reading...Stressed Out in Seattle – And Apparently Everywhere Else
11 November 2009 – 6:00 am PST
Comments Off
In the last several years, many of us have felt as though the level of stress in our lives is rising.A new study by the American Psychological Association (APA), with the cheery title of “The Stress in America Surveyâ€, backs up these gut feelings with hard data—75% of Americans say stress is impacting their lives. [...]
Continue reading...Enzon Sigma-Tau Agreement (NASDAQ:ENZN)
10 November 2009 – 7:00 am PST
Comments Off
Enzon Pharmaceuticals, Inc (NASDAQ:ENZN) has announced that they have entered into a definitive agreement to sell their specialty pharmaceutical business to Sigma-Tau Group for US$300 million along with milestone payments of US$27 million.
Continue reading...How Not to Find a Job (It’s Easy)
10 November 2009 – 6:30 am PST
Newly released information from the U.S. Department of Labor continues to paint a grim picture about the job market. In October, 190,000 more jobs were lost and the national unemployment rate rose to 10.2 percent.
Continue reading...Ziopharm Shows Positive Results (NASDAQ:ZIOP)
9 November 2009 – 10:05 am PST
Comments Off
Ziopharm Oncology, Inc. (NASDAQ:ZIOP) has announced today and presented their positive interim data from the multicenter randomized Phase 2 trial of Palifosfamide also known as Zymafos that will be used for the treating patients with unresectable or metastatic soft tissue sarcoma.
Continue reading...PPD Acquires Excel PharmaStudies (NASDAQ:PPDI)
9 November 2009 – 10:05 am PST
Comments Off
PPD or Pharmaceutical Product Development, Inc (NASDAQ:PPDI) today announced that they have completed their acquisition of Excel PharmaStudies Inc which is considered to be the market leader and one of the largest contract research organizations in China.
Continue reading...QuantRx’s Diagnostic Reader (OTC:QTXB)
9 November 2009 – 10:05 am PST
Comments Off
QuantRx Biomedical Corporation (OTC:QTXB) has announced that the Company will soon demonstrate its latest technology at the MEDICA 2009.
Continue reading...NovaDel’s USPTO Allowance Notice (AMEX:NVD)
6 November 2009 – 8:00 am PST
Comments Off
NovaDel Pharma Inc. (AMEX:NVD) announced that they have received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. Patent Application No. 10/671,715 entitled “Buccal, Polar and Non-Polar Spray containing Zolpidem†that covers a method of treating insomnia by administering zolpidem to human beings utilizing NovaMist Oral Spray [...]
Continue reading...Entest Biomedical COPD Treatments (OTC:ENTB)
6 November 2009 – 7:45 am PST
Comments Off
Entest Biomedical Inc (OTC:ENTB) announced that the Company’s unique treatments for Chronic Obstructive Pulmonary Disease also known as COPD, which is currently under development, can lead to substantial revenue opportunities in the near future.
Continue reading...
11 November 2009 – 8:30 am PST
Comments Off